Aims: Hypophysitis is a rare chronic inflammation of the pituitary gland corresponding currently to six histopathological subtypes. Among them, immunoglobulin- G4-related hypophysitis was recently added in this classification. The aim of this study was to perform a retrospective histopathological and immunohistochemical analysis to evaluate the prevalence of IgG4-related hypophysitis and review reported cases.
Methods: All samples of hypophysitis from Lariboisiere hospital were reviewed by two pathologists to assess their subtypes. An immunohistochemistry against IgG4 and IgG was performed. Slides were numerized, and IgG4-positive plasma cells and IgG plasma cells were counted in three high-power fields to evaluate the ratio.
Results: Eight cases were included: 5 lymphocytic hypophysitis, 1 granulomatous subtype, and 2 IgG4-related hypophysitis, affecting two young women without other coaffected organ.
Conclusion: Our results show that IgG4-related hypophysitis is not an exceptional entity. Storiform fibrosis and obliterative phlebitis, histopathological characteristics of IgG4-related disease in other organs, are lacking in pituitary lesions. This study proves the interest of immunohistochemistry for diagnosis of IgG4-related hypophysitis. Due to the sensibility of IgG4-disease to steroids in other organs, this finding could be of clinical relevance.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5414/NP300841 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Paraneoplastic endocrine syndromes: a contemporary overview.
Expert Rev Endocrinol Metab
January 2025
Carrera de Medicina Humana, Universidad Científica del Sur, Lima, Perú.
Introduction: Endocrine paraneoplastic syndromes (ePNS) are caused by malignant cells that induce hormonal alterations unrelated to the tissue of origin of the neoplasm. The aim of this manuscript is to review the pathophysiology, diagnosis, and treatment of endocrine paraneoplastic syndromes (ePNS).
Areas Covered: We searched the PubMed/Medline, Embase, and Scielo databases, including 96 articles.
Utility of F18-FDG PET/CT in the Evaluation of Pituitary Uptake.
World J Nucl Med
December 2024
Department of Nuclear Medicine, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
Pituitary adenoma is the most common disease that affects the gland and may be classified as functional/nonsecretory tumors. Inflammatory/infective causes may also affect the pituitary gland. The 18F-fluorodeoxyglucose positron emission tomography/computed tomography (F18-FDG PET/CT) may have an incremental value in assessing these lesions and in determining their clinical significance.
View Article and Find Full Text PDFPembrolizumab-induced Thyroiditis, Hypophysitis and Adrenalitis: A Case of Triple Endocrine Dysfunction.
JCEM Case Rep
November 2024
Endocrinology Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona 60126, Italy.
Article Synopsis
- - Immune checkpoint inhibitors, like pembrolizumab used in melanoma treatment, can cause rare autoimmune reactions affecting endocrine glands, leading to conditions like hyperthyroidism and hypothyroidism.
- - A 39-year-old man experienced a sequence of endocrine issues following his pembrolizumab treatment, including thyrotoxicosis, hypothyroidism, and central adrenal insufficiency.
- - This case highlights the need for careful monitoring of hormonal functions in patients undergoing immunotherapy due to the variability and unusual nature of these endocrine side effects.
Isolated IgG4-related Infundibulo-hypophysitis.
JCEM Case Rep
October 2024
Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, WI 53226 USA.
A 72-year-old man presented with several months of weakness, poor appetite, and depressed moods. Laboratory tests indicated central hypocortisolism, hypothyroidism and hypogonadism, and mild hyperprolactinemia. Imaging indicated a homogenously enhancing solid suprasellar mass inseparable from the hypothalamus and contiguous with a thickened proximal infundibulum.
View Article and Find Full Text PDFHypophysitis in COVID-19: a systematic review.
Pituitary
December 2024
Pituitary Unit, Department of Endocrinology and Diabetes, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Article Synopsis
- This systematic review investigates recent cases of hypophysitis—an inflammation of the pituitary gland—in patients who have recovered from COVID-19.
- Seven cases were studied, mainly involving young adults, with symptoms like headaches and increased thirst, emerging 2-3 weeks after COVID-19 symptoms.
- The findings showed various imaging results, with some patients receiving glucocorticoid treatment, but long-term follow-up data was limited, highlighting the rarity and unique presentation of COVID-related hypophysitis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!